UnitedHealth Group’s shares fell sharply on Thursday after reporting fourth-quarter results below Wall Street’s expectations. The health insurer reported a medical cost ratio (MCR) of 86-87%, higher than its first quarter 2023 MCR of 82%. This led to a decline in the company’s stock price, falling 6% to $510.59.
The decline followed failed attempts by bulls to close above the 200-day moving average. Thursday’s drop was also notable for being the highest trading volume since the stock’s sharp move lower last month. Investors are now watching key support levels at $475 and $436, while also monitoring overhead areas near $550 and $605.
The company maintained its 2025 outlook unchanged, citing higher medical costs. However, investors should be cautious of these levels as they could provide significant support or resistance for the stock price. The shares are down nearly 20% from their record high set in November but have been virtually unchanged from a year ago.
Source: https://www.investopedia.com/watch-these-unitedhealth-price-levels-as-stock-slumps-after-disappointing-results-8776323